Company Filing History:
Years Active: 2019
Title: Innovations in Ovarian Cancer Prognosis by Jonathan Berek
Introduction
Jonathan Berek is a prominent inventor based in Stanford, California. He has made significant contributions to the field of cancer research, particularly in the prognosis and diagnosis of ovarian cancer. His work focuses on identifying cellular markers that can indicate a poor prognosis for patients suffering from this disease.
Latest Patents
Berek holds a patent titled "Methods of prognosis and diagnosis of ovarian cancer." This patent discloses cellular markers that indicate a poor prognosis for ovarian cancer patients. Specifically, the invention relates to methods that utilize the frequency of a subset of cells in ovarian tumor tissue expressing vimentin, cMyc, or HE4, or any combination thereof, to predict whether an ovarian cancer patient will relapse. He has 1 patent to his name.
Career Highlights
Jonathan Berek is affiliated with Leland Stanford Junior University, where he continues to advance research in oncology. His work has been instrumental in developing new methods for cancer diagnosis and prognosis, which can significantly impact patient care and treatment strategies.
Collaborations
Berek has collaborated with notable colleagues in his field, including Wendy Fantl and Veronica Gonzalez. Their combined expertise contributes to the ongoing research and development of innovative solutions for cancer diagnosis.
Conclusion
Jonathan Berek's contributions to the field of ovarian cancer research highlight the importance of innovation in medical science. His patented methods for prognosis and diagnosis are paving the way for improved patient outcomes in the fight against cancer.